Home » Authors » Don Long

Articles by Don Long

Still Focused On Intercept, Cerus Cuts Work Force By 25 Percent

Oct. 17, 2003

Phillips marries its monitoring, AED expertise in the MRx

Oct. 1, 2003

Corautus Gets Lift From Boston Scientific Deal Worth Up To $25M

Aug. 1, 2003

By Don Long and Aaron Lorenzo

PPD Expands Into Device Sector, Spins Off Functional Genomics

July 18, 2003

PPD Expands Into Device Sector, Spins Off Functional Genomics

July 18, 2003

Northfield Gets Positive News On Blood Product; Hemosol Set Back

June 13, 2003

Northfield Gets Positive News On Blood Product; Hemosol Set Back

June 13, 2003

Cerus Raises $54.3M In Public Offering For Intercept Product

June 9, 2003

Cerus Raises $54.3M In Public Offering For Intercept Product

June 9, 2003

Infigen's Three Miniature Swine A Step In Transplantation Trail

March 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...